Abstract
Babesia gibsoni is an intraerythrocytic apicomplexan parasite that causes piroplasmosis in dogs. B. gibsoni infection is characterized clinically by fever, regenerative anemia, splenomegaly, and sometimes death. Since no vaccine is available, rapid and accurate diagnosis and prompt treatment of infected animals are required to control this disease. Over the past decade, several candidate molecules have been identified using biomolecular techniques in the authors’ laboratory for the development of a serodiagnostic method, vaccine, and drug for B. gibsoni. This review article describes newly identified candidate molecules and their applications for diagnosis, vaccine production, and drug development of B. gibsoni.
| Original language | English |
|---|---|
| Pages (from-to) | 345-354 |
| Number of pages | 10 |
| Journal | Korean Journal of Parasitology |
| Volume | 52 |
| Issue number | 4 |
| DOIs | |
| State | Published - 1 Aug 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Babesia gibsoni
- Drug
- Serodiagnosis
- Vaccine
Fingerprint
Dive into the research topics of 'New molecules in Babesia gibsoni and their application for diagnosis, vaccine development, and drug discovery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver